Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2000
03/29/2000CN1248629A Process for producing taxus alkane diterpene
03/29/2000CN1050861C Artificial seed storing method obtained from controllable culture of body cell embryo
03/28/2000US6043348 Antibody recognizing a small subset of human hematopoietic cells
03/28/2000US6043343 Amino acid sequence; for diagnosis and prevention of cancer and tumors; anticarcinogenic/antitumor agents; for screening compounds which bind to polypeptide
03/28/2000US6043221 Method for preventing and treating hearing loss using a neuturin protein product
03/28/2000US6043211 Adding to a first protein a peptide analogue of a phosphorylated region, whereupon the binding of said first protein to said second protein is inhibited
03/28/2000US6043094 Therapeutic liposome composition and method
03/28/2000US6043092 Serum-free mixture for expansion of hepatocytes; of basal medium, nicotinamide, transferrin chelated with iron, insulin or insulin-like growth factors, glucocorticoid steroid, trace metals, glucose or galactose, arginine, proline, glutamine
03/28/2000US6043089 Skin-derived cells on matrix of collagen sponge, sheet or gel prepared in a structure having projections; sufficient nutrition supply, smooth discharge of exudate, contraction inhibition, retains cells; for covering defects
03/28/2000US6043088 Nucleotide sequence; dna and rna probes for diagnosis; anticarcinogenic/antitumor agents; vectors for gene therapy
03/28/2000US6043087 Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen)
03/28/2000US6043085 Nucleotide and amino acid sequences; for treatment of infections/bactericides
03/28/2000US6043077 Directed aganist specific nucleotide sequences to inhibit replication, infectivity, or gene expression of the virus; for prevention or viricides with side effect reduction
03/28/2000US6043073 Phospholipase D polypeptide and DNA sequences
03/28/2000US6043072 Nucleic acids encoding Taxus geranylgeranyl diphosphate synthase, and methods of use
03/28/2000US6043071 GlmU
03/28/2000US6043066 Cell separation using electric fields
03/28/2000US6043056 Amino acid sequences; for diagnosis, treatment, and prevention of blood, karyotypic, and nervous system disorders
03/28/2000US6043053 Wnt-3 polynucleotides
03/28/2000US6043052 Nucleotide and amino acid sequences of g protein coupled receptor; for diagnosis and treatment of related diseases; anticarcinogenic/antidiabetic/antiulcer agents; antidepressants; hypotensive/hypertensive agents
03/28/2000US6043040 Csak-3 nucleic acid molecules and uses therefor
03/28/2000US6042835 Prototype FelV isolates for use in disease models and vaccines
03/28/2000US6042832 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins
03/28/2000US6042827 Anti-idiotypic antibody induction of anti-tumor response
03/28/2000CA2245903A1 Use of pex in the treatment of metabolic bone diseases
03/28/2000CA2020572C Process for the preservation of plant embryos
03/28/2000CA2008735C Human epidermal growth factor (egf) receptor sequences and egf competitive monoclonal antibodies
03/23/2000WO2000015853A1 Recombinant newcastle disease virus rna expression systems and vaccines
03/23/2000WO2000015845A1 T-type calcium channel
03/23/2000WO2000015826A2 Leptin induced genes
03/23/2000WO2000015824A1 Transfer method for specific cellular localisation of nucleic acids
03/23/2000WO2000015820A1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof
03/23/2000WO2000015819A1 Packaging cell lines for hiv-derived retroviral vector particles
03/23/2000WO2000015816A2 Maize replication protein a
03/23/2000WO2000015813A1 Methods for producing genetically modified plants, plant materials and plant products produced thereby
03/23/2000WO2000015809A2 Uracil permease from arabidopsis as herbicidal target gene
03/23/2000WO2000015807A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000WO2000015806A1 Atp synthase subunit homolog
03/23/2000WO2000015805A1 Use of protein kinase kiaa0551 as pharmaceutical
03/23/2000WO2000015802A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000WO2000015796A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/23/2000WO2000015794A1 Human cell junction pdz protein
03/23/2000WO2000015793A2 Human gpcr proteins
03/23/2000WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization
03/23/2000WO2000015791A1 Ecdysone receptors and methods for their use
03/23/2000WO2000015790A2 Leptin induced genes
03/23/2000WO2000015788A2 Dna sequence encoding oncofetal ferritin protein
03/23/2000WO2000015787A1 Genes encoding for the human and murine death inducer-obliterator-1
03/23/2000WO2000015786A1 Metabotropic gaba receptor complex issued from the central nervous system
03/23/2000WO2000015784A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
03/23/2000WO2000015775A1 Rnase p polypeptides
03/23/2000WO2000015772A2 Recombinant protein production in urine
03/23/2000WO2000015771A1 Recombinant vanadium haloperoxidases and their uses
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015769A1 Topa
03/23/2000WO2000015768A1 Immune activation by double-stranded polynucleotides
03/23/2000WO2000015767A2 Antigen-presenting cells and their use in therapy
03/23/2000WO2000015765A1 Enhanced submucosal tissue graft constructs
03/23/2000WO2000015764A2 Propagation and/or derivation of embryonic stem cells
03/23/2000WO2000015763A1 Utilization of nanocells in final culture medium products
03/23/2000WO2000015760A1 Streptococcal c beta protein compositions
03/23/2000WO2000015759A1 Interleukin 17-like receptor protein
03/23/2000WO2000015758A2 Plant resistance to insect pests mediated by viral proteins
03/23/2000WO2000015666A2 Compositions and methods for the treatment of tumors
03/23/2000WO2000015659A2 Stomach polypeptide zsig28
03/23/2000WO2000015650A1 Polynucleotide and polypeptide sequences encoding rat mdr1a and screening methods thereof
03/23/2000WO2000015649A1 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130
03/23/2000WO2000015258A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
03/23/2000WO2000015246A2 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
03/23/2000WO2000008160A3 A plant disease resistance signalling gene: materials and methods relating thereto
03/23/2000WO2000008137A3 Transgenic animals having a modified glycoprotein v gene
03/23/2000WO2000006747A3 Enzymes for biopolymer production
03/23/2000WO2000003244A9 Immortalized human keratinocyte cell line
03/23/2000WO2000002520A3 T-lymphocyte exchange
03/23/2000WO2000000611A3 14273 receptor, a g-protein coupled receptor
03/23/2000WO1999067359A3 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
03/23/2000WO1999056773A9 Composition comprising tumor cells and extracts and method of using thereof
03/23/2000WO1999055876A3 Polypeptide with immunogenic properties and with a protein with modified biological functions
03/23/2000WO1999053100A3 Method for finding genetic markers of somaclonal variation
03/23/2000WO1999053061A3 Tumor associated nucleic acids and uses therefor
03/23/2000WO1996040039A3 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
03/23/2000DE19843234A1 Differentiated heart cells for use as in-vitro models for heart disease are produced by embryoid body differentiation under abnormal conditions
03/23/2000DE19842802A1 Culture system for stimulating the growth and differentiation of cartilage and/or bone cells comprises a combination of undifferentiated cells and differentiating and/or differentiated cells
03/23/2000DE19816732A1 Diagnostik und Therapie von Erkrankungen im Zusammenhang mit HHV-8-Infektionen Diagnosis and treatment of diseases associated with HHV-8 infection
03/23/2000CA2641651A1 Immune activation by double-stranded polynucleotides
03/23/2000CA2343838A1 Atp synthase subunit homolog
03/23/2000CA2343654A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/23/2000CA2343577A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/23/2000CA2343574A1 Metabotropic gaba receptor complex issued from the central nervous system
03/23/2000CA2343220A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
03/23/2000CA2343104A1 Recombinant protein production in urine
03/23/2000CA2343051A1 Streptococcal c beta protein compositions
03/23/2000CA2343001A1 Stomach polypeptide zsig28
03/23/2000CA2342965A1 Leptin induced genes
03/23/2000CA2342958A1 Rna-associated proteins
03/23/2000CA2342833A1 Human gpcr proteins
03/23/2000CA2342589A1 Enhanced submucosal tissue graft constructs
03/23/2000CA2342398A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000CA2342301A1 Human cell junction pdz protein
1 ... 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 ... 1827